NOTICES: National Heart, Lung, and Blood Institute,
Published: 2007-12-26
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the
NOTICES: American Health Information Community,
Published: 2007-12-26
This notice announces the 21st meeting of the American Health
Information Community Chronic Care Workgroup in accordance with the
Federal Advisory Committee Act (Pub. L. 92463, 5 U.S.C., App.)
NOTICES: National Institute of Diabetes and Digestive and Kidney Diseases,
Published: 2007-12-26
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-21
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to
NOTICES: Pulmonary-Allergy Drugs Advisory Committee,
Published: 2007-12-21
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: PulmonaryAllergy Drugs Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
NOTICES: Dietary lipids and cancer, soy protein and coronary heart disease, antioxidant vitamins and cancers, and selenium and cancers; health claims; reevaluation,
Published: 2007-12-21
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on its intent to reevaluate the
scientific evidence for two previously authorized health claims
(dietary lipids (fat) and cancer; soy protein and risk of coronary
heart disease) and two qualified health claims that were the subject of
letters of enforcement
NOTICES: Interagency Center for Evaluation of Alternative Toxicological Methods; ten-year anniversary symposium and five-year plan,
Published: 2007-12-21
NICEATM invites attendance at a public symposium to mark the
tenth anniversary of ICCVAM. The symposium, entitled ``Celebrating Ten
Years of Advancing Public Health and Animal Welfare With Sound Science:
Envisioning New Directions in Toxicology'' will be held February 5,
2008, at the U.S. Consumer Product Safety Commission (CPSC)
Headquarters in
NOTICES: Potential eligibility for compensation announcment; declaration and filing deadlines,
Published: 2007-12-21
This Notice provides notification that individuals who have
been injured by pandemic, epidemic, or security countermeasures
identified in a declaration issued by the Secretary pursuant to section
319F3(b) of the Public Health Service Act (PHS Act) (42 U.S.C. 247d
6d) have one (1) year from the time they receive the covered
countermeasure to file
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-21
In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Cancer Institute
(NCI) of the National Institutes of Health (NIH) will publish periodic
summaries of proposed projects to be submitted to the Office of
Management
NOTICES: Inventions, Government-owned; availability for licensing,
Published: 2007-12-21
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federally funded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: Privacy Act; systems of records,
Published: 2007-12-21
In accordance with the requirements of the Privacy Act of
1974, we are proposing to establish a new system titled, ``Money
Follows the Person (MFP) Demonstration (MFPD), System No. 09700593.''
The demonstration, created by section 6071 of the Deficit Reduction Act
of 2005 (Pub. L. 109171), provides to states a total of $1.75 billion
in competitive
NOTICES: Privacy Act; systems of records,
Published: 2007-12-21
In accordance with the requirements of the Privacy Act of
1974, we are proposing to establish a new system titled, ``Home and
CommunityBased Alternatives (CBA) to Psychiatric Residential Treatment
Facilities (PRTF) Demonstration (CBAPRTF), System No. 09700594.''
The demonstration, created by section 6063 of the Deficit Reduction Act
of 2005 (Pub.
NOTICES: National Institute of Nursing Research,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council for Nursing Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special
NOTICES: National Institute on Drug Abuse,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council on Drug Abuse.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special
NOTICES: National Institute on Drug Abuse,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions
NOTICES: National Institute on Drug Abuse,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: Recombinant DNA Advisory Committee,
Published: 2007-12-20
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-20
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-20
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-20
Title: Information Comparison with Insurance Data.
OMB No.: New Collection.
Description: The Deficit Reduction Act of 2005 amended section 452
of the Social Security Act (the Act) to authorize the Secretary of
Health and Human Services, through the Federal Parent Locator Service
(FPLS), to conduct comparisons of information concerning
NOTICES: National Cancer Institute,
Published: 2007-12-20
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
NOTICES: National Institute of Allergy and Infectious Diseases,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
aamended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Institute of Allergy and Infectious Diseases,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Dental and Craniofacial Research,
Published: 2007-12-20
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors, National Institute of Dental and Craniofacial Research.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in
NOTICES: Premarket approval applications, list; safety and effectiveness summaries availability,
Published: 2007-12-19
The Food and Drug Administration (FDA) is publishing a list of
premarket approval applications (PMAs) that have been approved. This
list is intended to inform the public of the availability of safety and
effectiveness summaries of approved PMAs through the Internet and the
agency's Division of Dockets Management.